Final Text
18VAC110-20-322. Placement of chemicals in Schedule I.
A. Pursuant to § 54.1-3443 D of the Code of Virginia, the Board of Pharmacy places the following substances in Schedule I of the Drug Control Act:
1. Cannabimimetic agents:
a. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other names: ADB-CHMINACA, MAB-CHMINACA);
b. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other name: 5-fluoro-AMB);
c. 1-naphthalenyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (other name: NM-2201); and
d. 1-(4-fluorobenzyl)-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: FUB-144).
2. Substituted cathinones:
a. 4-bromomethcathinone (other name: 4-BMC); and
b. 4-chloromethcathinone (other name: 4-CMC).
The placement of drugs in this subsection shall remain in effect until February 11, 2017, unless enacted into law in the Drug Control Act.
B. Pursuant to subsection D of § 54.1-3443 of the Code of Virginia, the Board of Pharmacy places the following in Schedule I of the Drug Control Act:
1. Acetyl fentanyl (other name: desmethyl fentanyl).
2. Etizolam.
3. 4-Iodo-2, 5-dimethoxy-N-[(2-hydroxyphenyl) methyl]-benzeneethanamine (other name: 25I-NBOH).
4. Cannabimimetic agent:
1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl) indole (MAM-2201).
5. Substituted cathinones:
a. Alpha-Pyrrolidinohexiophenone (other name: alpha-PHP); and
b. Alpha-Pyrrolidinoheptiophenone (other name: PV8).
The placement of drugs listed in this subsection shall remain in effect until June 1, 2017, unless enacted into law in the Drug Control Act.
C. Pursuant to subsection D of § 54.1-3443 of the Code of Virginia, the Board of Pharmacy places the following in Schedule I of the Drug Control Act:
1. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide (other name: butyryl fentanyl)
2. Flubromazolam
3. 5-methoxy-N,N-methylisopropyltryptamine (Other name: 5-MeO-MIPT)
4. Cannabimimetic agents:
a. N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide (other name: ADB-FUBINACA)
b. Methyl 2-[1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (other name: MDMB-FUBINACA)
c.Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (other names: 5-fluoro-ADB, 5-Fluoro-MDMB-PINACA)
The placement of drugs listed in this subsection shall remain in effect until (18 months from the effective date), unless enacted into law in the Drug Control Act.